Published in Cancer Weekly, July 15th, 1996
Mitotix is currently using the p27 gene and protein in its drug discovery efforts to develop therapeutic products for the treatment of cancer and certain cardiovascular conditions. "p27's natural role as an inhibitor of cell division provides a distinctive approach to developing therapeutics to prevent inappropriate cell proliferation,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.